Cellular Cancer Markers: Contemporary Biomedicine, cartea 12
Editat de Carleton T. Garrett, Stewart Sellen Limba Engleză Hardback – 3 mar 1995
Cellular Cancer Markers provides a status report for markers of tumor cell activation, proliferation, and longevity that makes possible an informed judgment regarding the value of many newly proposed tumor markers. It also offers insight into the latest approaches to diagnosing cancer and an appreciation of how these marker-based tests can clarify the prognosis of cancer.
Toate formatele și edițiile | Preț | Express |
---|---|---|
Paperback (1) | 1581.64 lei 6-8 săpt. | |
Humana Press Inc. – 17 sep 2011 | 1581.64 lei 6-8 săpt. | |
Hardback (1) | 1403.87 lei 6-8 săpt. | |
Humana Press Inc. – 3 mar 1995 | 1403.87 lei 6-8 săpt. |
Din seria Contemporary Biomedicine
- 5% Preț: 1084.42 lei
- 5% Preț: 1407.83 lei
- 15% Preț: 645.69 lei
- 5% Preț: 1101.50 lei
- 5% Preț: 1299.40 lei
- 5% Preț: 1412.51 lei
- 5% Preț: 1411.77 lei
- 5% Preț: 719.11 lei
- 5% Preț: 1407.99 lei
- 5% Preț: 706.92 lei
- 18% Preț: 944.71 lei
- 5% Preț: 718.76 lei
- 18% Preț: 1220.76 lei
- 5% Preț: 713.21 lei
- 5% Preț: 720.74 lei
- 8% Preț: 502.62 lei
- 8% Preț: 536.52 lei
- Preț: 455.68 lei
- Preț: 394.19 lei
- 8% Preț: 538.88 lei
Preț: 1403.87 lei
Preț vechi: 1477.76 lei
-5% Nou
Puncte Express: 2106
Preț estimativ în valută:
268.67€ • 280.59$ • 222.75£
268.67€ • 280.59$ • 222.75£
Carte tipărită la comandă
Livrare economică 11-25 februarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780896032101
ISBN-10: 0896032108
Pagini: 484
Ilustrații: XII, 484 p.
Dimensiuni: 155 x 235 x 27 mm
Greutate: 0.87 kg
Ediția:1995
Editura: Humana Press Inc.
Colecția Humana
Seria Contemporary Biomedicine
Locul publicării:Totowa, NJ, United States
ISBN-10: 0896032108
Pagini: 484
Ilustrații: XII, 484 p.
Dimensiuni: 155 x 235 x 27 mm
Greutate: 0.87 kg
Ediția:1995
Editura: Humana Press Inc.
Colecția Humana
Seria Contemporary Biomedicine
Locul publicării:Totowa, NJ, United States
Public țintă
Professional/practitionerCuprins
Ch. 1. Clinical Application of Genetic, Oncogenic, and Differentiation Markers of Cancer.- Ch. 2. ras Proto-Oncogene Activation in Human Malignancy.- Ch. 3. C-myc as a Tumor Marker for Primary Human Cancers.- Ch. 4. p53 in Human Cancer.- Ch. 5. Oncogenes and Tumor-Suppressor Genes in Gynecological Malignancies.- Ch. 6. Genetic Alterations in Colon Cancer.- Ch. 7. Genetic Changes in Breast Cancer.- Ch. 8. Genetic Alterations in Lung Cancer.- Ch. 9. Wilms Tumor-Susceptibility Loci.- Ch. 10. Non-Hodgkin’s Lymphomas.- Ch. 11. Phenotypic Expression of Hodgkin’s Disease: Biologic, Immunologic, and Functional Properties of Reed-Sternberg Cells.- Ch. 12. Melanoma Markers.- Ch. 13. Detection of Minimal Residual Disease (MRD) in Leukemia and Lymphoma.- Ch. 14. P-Glycoproteins in Tumors.- Ch. 15. Genetically Engineered Antitumor Monoclonal Antibodies.- Ch. 16. Targeting Antisense Oligonucleotide Chemotherapy to the Type I Regulatory Subunit of cAMP-Dependent Protein Kinase.- Ch. 17. Summary and Perspective: Assessing Test Effectiveness—The Identification of Good Tumor Markers.
Recenzii
The editors should be commended for attempting an extensive compilation of information on cancer markers...-New England Journal of Medicine